ATE245448T1 - Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten - Google Patents
Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthaltenInfo
- Publication number
- ATE245448T1 ATE245448T1 AT97900169T AT97900169T ATE245448T1 AT E245448 T1 ATE245448 T1 AT E245448T1 AT 97900169 T AT97900169 T AT 97900169T AT 97900169 T AT97900169 T AT 97900169T AT E245448 T1 ATE245448 T1 AT E245448T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- cell death
- influx
- influx blocker
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58400096A | 1996-01-11 | 1996-01-11 | |
| PCT/CA1997/000019 WO1997025063A1 (en) | 1996-01-11 | 1997-01-13 | Compositions including calcium influx blockers for inhibiting cell growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE245448T1 true ATE245448T1 (de) | 2003-08-15 |
Family
ID=24335483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97900169T ATE245448T1 (de) | 1996-01-11 | 1997-01-13 | Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0873137B1 (de) |
| JP (1) | JP2000513708A (de) |
| KR (1) | KR19990077183A (de) |
| CN (1) | CN1099296C (de) |
| AT (1) | ATE245448T1 (de) |
| AU (1) | AU732012B2 (de) |
| BR (1) | BR9710942A (de) |
| CA (1) | CA2242866A1 (de) |
| DE (1) | DE69723670D1 (de) |
| IL (1) | IL125297A0 (de) |
| PL (1) | PL327921A1 (de) |
| TR (1) | TR199801359T2 (de) |
| WO (1) | WO1997025063A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000054332A (ko) * | 2000-06-01 | 2000-09-05 | 김진경 | 혈관내피세포 성장인자 억제제에 의한 암 치료법 |
| WO2004013629A2 (en) * | 2002-07-29 | 2004-02-12 | Novartis Ag | Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| KR100573881B1 (ko) * | 2003-11-29 | 2006-04-26 | 장양수 | 허혈증상 치료제 |
| CN104324039A (zh) * | 2014-10-20 | 2015-02-04 | 付茜 | 一种治疗人身体表面脂肪瘤的药剂及使用方法 |
| CN110106146B (zh) * | 2019-03-28 | 2021-04-02 | 中国人民解放军军事科学院军事医学研究院 | 化合物富马酸酮替芬在促进干细胞因子合成和分泌中的用途 |
| CN113384551B (zh) * | 2021-05-07 | 2022-03-08 | 西安交通大学 | 一种减少肿瘤内过量钙离子的仿生纳米载体的制备方法和应用 |
-
1997
- 1997-01-13 JP JP09524697A patent/JP2000513708A/ja active Pending
- 1997-01-13 EP EP97900169A patent/EP0873137B1/de not_active Expired - Lifetime
- 1997-01-13 PL PL97327921A patent/PL327921A1/xx unknown
- 1997-01-13 DE DE69723670T patent/DE69723670D1/de not_active Expired - Lifetime
- 1997-01-13 BR BR9710942-8A patent/BR9710942A/pt not_active Application Discontinuation
- 1997-01-13 TR TR1998/01359T patent/TR199801359T2/xx unknown
- 1997-01-13 AU AU13628/97A patent/AU732012B2/en not_active Ceased
- 1997-01-13 CA CA002242866A patent/CA2242866A1/en not_active Abandoned
- 1997-01-13 IL IL12529797A patent/IL125297A0/xx unknown
- 1997-01-13 KR KR1019980705324A patent/KR19990077183A/ko not_active Application Discontinuation
- 1997-01-13 AT AT97900169T patent/ATE245448T1/de not_active IP Right Cessation
- 1997-01-13 CN CN97192863A patent/CN1099296C/zh not_active Expired - Fee Related
- 1997-01-13 WO PCT/CA1997/000019 patent/WO1997025063A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN1099296C (zh) | 2003-01-22 |
| AU1362897A (en) | 1997-08-01 |
| CA2242866A1 (en) | 1997-07-17 |
| DE69723670D1 (de) | 2003-08-28 |
| JP2000513708A (ja) | 2000-10-17 |
| KR19990077183A (ko) | 1999-10-25 |
| EP0873137A1 (de) | 1998-10-28 |
| TR199801359T2 (xx) | 1998-10-21 |
| EP0873137B1 (de) | 2003-07-23 |
| WO1997025063A1 (en) | 1997-07-17 |
| BR9710942A (pt) | 2000-10-24 |
| PL327921A1 (en) | 1999-01-04 |
| AU732012B2 (en) | 2001-04-12 |
| IL125297A0 (en) | 1999-03-12 |
| CN1213315A (zh) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9306239A (es) | Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma. | |
| NO921875D0 (no) | Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
| CA2023810A1 (fr) | Compositions pharmaceutiques de type "pates a l'eau" | |
| MY104535A (en) | Oral composition for the treatment of inflammatory bowel diseases. | |
| ATE219674T1 (de) | Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika | |
| ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
| PE30891A1 (es) | Composiciones y metodos terapeuticos sinergicos | |
| AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
| ATE364699T1 (de) | Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen | |
| DE60040753D1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| DE69332713D1 (de) | Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen | |
| ATE227717T1 (de) | 3-pyridylenantiomere und ihre verwendung als analgetika | |
| ATE135208T1 (de) | Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen | |
| PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
| ATE187642T1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| ES2135769T3 (es) | Derivados de isotiourea como inhibidores de no-sintasa. | |
| ATE240725T1 (de) | Mittel zur behandlung lichtgeschädigter haut die einen rar-alpha antagonisten und ein multiselektives retinoid enthalten | |
| DE69825279D1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
| ATE245448T1 (de) | Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten | |
| ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| MX9300205A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. | |
| BR9911756A (pt) | Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto | |
| ATE222768T1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |